Location
Grand Cayman, Cayman Islands
Signature
Decheng Capital China Life Sciences USD Fund III, L.P., By Decheng Capital Management III (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Decheng Capital China Life Sciences USD Fund III, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALPINE IMMUNE SCIENCES, INC. 10%+ Owner Common Stock 6,582,380 $83,859,521 $12.74 18 Jan 2024 Direct
BeyondSpring Inc. 10%+ Owner Ordinary Shares 1,617,409 $2,814,291 $1.74 16 Oct 2025 By Decheng Capital China Life Sciences USD Fund II, L.P.
BeyondSpring Inc. 10%+ Owner Ordinary Shares 1,518,893 $2,673,251 $1.76 17 Oct 2025 By Decheng Capital China Life Sciences USD Fund III, L.P.
Cue Health Inc. 10%+ Owner Common Stock 8,192,468 $2,457,740 $0.3000 28 Sep 2021 Direct
BeyondSpring Inc. 10%+ Owner Ordinary Shares 891,734 $1,551,617 $1.74 16 Oct 2025 By Decheng Capital Global Healthcare Fund (Master), LP
ALPINE IMMUNE SCIENCES, INC. 10%+ Owner Warrant (right to buy) 0 18 Jan 2024 Direct
Cue Health Inc. 10%+ Owner Series C-1 Preferred Stock 0 28 Sep 2021 Direct

Insider Reports Filed by Decheng Capital China Life Sciences USD Fund III, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BYSI BeyondSpring Inc. 16 Oct 2025 2 -$227,675 4 10%+ Owner 20 Oct 2025, 20:00
BYSI BeyondSpring Inc. 13 Oct 2025 3 -$259,164 4 10%+ Owner 15 Oct 2025, 20:07
BYSI BeyondSpring Inc. 08 Oct 2025 3 -$24,720 4 10%+ Owner 10 Oct 2025, 17:58
BYSI BeyondSpring Inc. 03 Oct 2025 3 -$35,965 4 10%+ Owner 07 Oct 2025, 18:14
BYSI BeyondSpring Inc. 30 Sep 2025 3 -$13,800 4 10%+ Owner 02 Oct 2025, 20:51
BYSI BeyondSpring Inc. 25 Sep 2025 3 -$3,045 4 10%+ Owner 29 Sep 2025, 20:06
BYSI BeyondSpring Inc. 22 Sep 2025 3 -$20,753 4 10%+ Owner 24 Sep 2025, 18:49
BYSI BeyondSpring Inc. 17 Sep 2025 3 -$19,995 4 10%+ Owner 19 Sep 2025, 18:03
BYSI BeyondSpring Inc. 12 Sep 2025 3 -$7,603 4 10%+ Owner 16 Sep 2025, 19:45
BYSI BeyondSpring Inc. 09 Sep 2025 3 -$40,866 4 10%+ Owner 11 Sep 2025, 19:43
BYSI BeyondSpring Inc. 04 Sep 2025 3 -$17,202 4 10%+ Owner 08 Sep 2025, 18:55
BYSI BeyondSpring Inc. 29 Aug 2025 3 -$8,675 4 10%+ Owner 03 Sep 2025, 19:57
BYSI BeyondSpring Inc. 26 Aug 2025 3 -$7,358 4 10%+ Owner 28 Aug 2025, 20:39
BYSI BeyondSpring Inc. 21 Aug 2025 3 -$10,120 4 10%+ Owner 25 Aug 2025, 19:46
BYSI BeyondSpring Inc. 18 Aug 2025 3 -$109,159 4 10%+ Owner 20 Aug 2025, 18:35
BYSI BeyondSpring Inc. 14 Aug 2025 2 -$9,800 4 10%+ Owner 15 Aug 2025, 19:11
BYSI BeyondSpring Inc. 17 Jun 2025 17 -$1,204,042 4 10%+ Owner 11 Aug 2025, 17:07
BYSI BeyondSpring Inc. 02 Jan 2025 0 $0 3 10%+ Owner 11 Aug 2025, 17:06
/report/000120919124002016-decheng-capital-china-life-sciences-usd-fund-iii-l-p-2024-01-18 ALPINE IMMUNE SCIENCES, INC. 18 Jan 2024 2 +$15,729,263 4 10%+ Owner 22 Jan 2024, 18:54
/report/000120919122051370-decheng-capital-china-life-sciences-usd-fund-iii-l-p-2022-09-23 ALPINE IMMUNE SCIENCES, INC. 23 Sep 2022 2 +$14,700,000 4 10%+ Owner 27 Sep 2022, 16:46
/report/000114036121033150-decheng-capital-china-life-sciences-usd-fund-iii-l-p-2021-09-28 Cue Health Inc. 28 Sep 2021 2 $0 4 10%+ Owner 30 Sep 2021, 17:48
/report/000114036121032358-decheng-capital-china-life-sciences-usd-fund-iii-l-p-2021-09-23 Cue Health Inc. 23 Sep 2021 0 $0 3 10%+ Owner 23 Sep 2021, 21:06
/report/000162619921000118-decheng-capital-china-life-sciences-usd-fund-iii-l-p-2021-09-17 ALPINE IMMUNE SCIENCES, INC. 17 Sep 2021 1 +$14,499,998 4 10%+ Owner 21 Sep 2021, 18:39